heart failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Decreased cardiac output - Heart failure often begins with the heart's inability to pump sufficient blood to meet the body's demands, usually due to weakened or stiffened heart muscles. This leads to a reduced ejection fraction, causing low perfusion to vital organs.

• Secondary mechanism: Compensatory neurohormonal activation - To counteract low cardiac output, the body activates the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system, which initially helps maintain blood pressure but eventually leads to fluid retention, vasoconstriction, and further cardiac strain.

• Key complication: Fluid overload - As compensatory mechanisms persist, they result in fluid retention, causing congestion in pulmonary and systemic circulation, leading to symptoms like edema and shortness of breath, which are hallmark presentations in heart failure patients.

Patient Profile

Demographics:

67-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, type 2 diabetes, previous myocardial infarction

• Current medications: Lisinopril, Metformin, Aspirin, Metoprolol

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath over the past week

• Key symptoms: Fatigue, orthopnea, mild peripheral edema, occasional palpitations

• Vital signs: Blood pressure 145/90 mmHg, heart rate 95 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

Change in Patient Status:

Following the initial assessment, the patient, Mr. Thompson, experienced a change in his status overnight. Nurses noted an increase in respiratory distress, with his respiratory rate rising to 28 breaths per minute, and his oxygen saturation dropping to 88% on room air. This prompted the initiation of supplemental oxygen via nasal cannula, which improved his oxygen saturation to 92%. Despite this intervention, Mr. Thompson continued to report severe dyspnea, particularly when lying flat, and required elevation to a semi-Fowler’s position to alleviate his symptoms. His heart rate increased to 105 bpm, and he exhibited increased fatigue and confusion, which raised concerns about potential hypoperfusion to the brain.

These changes in Mr. Thompson’s condition suggest worsening pulmonary congestion and possible progression towards acute decompensated heart failure. Clinical reasoning must consider the need for more aggressive diuresis to manage fluid overload, as evidenced by worsening peripheral edema and crackles upon auscultation of the lungs. Additionally, the increase in heart rate and confusion may indicate that the compensatory mechanisms are being overwhelmed, leading to increased cardiac workload and decreased cerebral perfusion. The healthcare team should consider further diagnostic evaluations, such as a chest X-ray and BNP levels, to assess the extent of fluid accumulation and cardiac stress. These findings will guide the adjustment of his medication regimen, potentially increasing diuretic therapy or considering advanced treatment options like inotropic support if cardiac output fails to improve.

Section 2

New Diagnostic Results:

Following the overnight changes in Mr. Thompson's condition, a series of diagnostic tests were conducted to gain a clearer understanding of his status. The chest X-ray revealed significant pulmonary congestion, with bilateral interstitial and alveolar edema, suggesting worsening heart failure. Additionally, his B-type Natriuretic Peptide (BNP) levels were markedly elevated at 1,200 pg/mL, confirming increased cardiac stress and fluid overload. These findings aligned with the clinical presentation of acute decompensated heart failure, prompting a reassessment of his current treatment regimen.

Laboratory results also indicated a mild elevation in creatinine levels at 1.5 mg/dL, up from his baseline of 1.0 mg/dL, raising concerns about renal function in the context of aggressive diuretic therapy. Electrolyte imbalances were noted, with a potassium level of 3.2 mmol/L, suggesting a risk for cardiac arrhythmias that required prompt correction. The combination of these diagnostic results underscored the need for careful titration of diuretics to manage fluid status while monitoring renal function and ensuring electrolyte repletion.

These diagnostic insights led the healthcare team to adjust Mr. Thompson's treatment plan. The diuretic dosage was increased with close monitoring of renal function and electrolytes. Furthermore, consideration was given to initiating low-dose inotropic support to enhance cardiac output and improve perfusion. This comprehensive approach aimed to stabilize Mr. Thompson's condition, providing a foundation for further interventions and ongoing monitoring to prevent further complications. The team remained vigilant for any signs of deterioration, as they prepared to reassess his clinical progress and response to the adjusted therapies.

Section 3

Following the adjustment in Mr. Thompson's treatment plan, the healthcare team closely monitored his clinical status to evaluate the efficacy of the interventions. Within 24 hours, his respiratory status showed modest improvement, evidenced by a decrease in respiratory rate from 28 to 22 breaths per minute and a reduction in the use of accessory muscles. Oxygen saturation levels stabilized at 94% on 2L nasal cannula, indicating a positive response to the increased diuretic therapy and improved pulmonary function. However, new challenges emerged as he began to exhibit signs of gastrointestinal discomfort, reporting nausea and a decreased appetite. This prompted the team to assess for potential side effects of the medications and ensure adequate nutritional support.

Lab work conducted in the morning revealed a slight improvement in his creatinine levels, now at 1.4 mg/dL, suggesting a cautious recovery of renal function amidst the diuretic adjustments. However, the potassium level remained low at 3.0 mmol/L, despite oral supplementation, necessitating the addition of intravenous potassium to prevent further complications such as arrhythmias. The team noted that Mr. Thompson's weight had decreased by 1.5 kilograms since admission, reflecting effective fluid removal but also raising concerns about potential dehydration and electrolyte shifts.

Clinically, Mr. Thompson appeared more alert and oriented, and he reported less fatigue, an encouraging sign of improved perfusion with the initiation of low-dose inotropic support. Nevertheless, the healthcare team remained vigilant, recognizing the delicate balance required to optimize cardiac output while preventing renal compromise and electrolyte imbalances. The next steps involved a comprehensive reassessment of his medication regimen and continued monitoring of his cardiac and renal function, with plans to re-evaluate his condition in 48 hours to determine any further modifications needed to sustain his recovery trajectory.

Section 4

As the healthcare team continued to monitor Mr. Thompson's progress, new diagnostic results revealed important insights into his current condition. Although his respiratory status had shown improvement, a follow-up chest X-ray indicated persistent pulmonary congestion, suggesting that the fluid overload was not yet fully resolved. Concurrently, an echocardiogram was performed, revealing a reduced ejection fraction of 35%, providing a clearer picture of the underlying severity of his heart failure. These findings prompted the team to consider further optimization of his heart failure management, possibly incorporating the introduction of an angiotensin receptor-neprilysin inhibitor (ARNI) to enhance cardiac function and mitigate fluid retention.

Meanwhile, Mr. Thompson's gastrointestinal symptoms persisted, with his nausea becoming more pronounced and accompanied by intermittent vomiting. This clinical picture raised suspicions of digoxin toxicity, as his digoxin level was found to be 2.5 ng/mL, higher than the therapeutic range. The team promptly held the digoxin dose and initiated supportive care to manage his symptoms. Additionally, his potassium level showed a slight increase to 3.4 mmol/L following the intravenous supplementation, but close monitoring was warranted to ensure stabilization and avoid further arrhythmic risks.

The healthcare team focused on a multi-disciplinary approach, involving a dietitian to address Mr. Thompson's nutritional needs given his decreased appetite and recent weight loss. Emphasis was placed on small, frequent meals and high-calorie, nutrient-dense options to support his recovery. As they continued to assess his response to interventions, the team remained vigilant for any new complications, particularly keeping an eye on his renal function and electrolyte balance. The next 48 hours would be crucial in determining whether adjustments to his treatment plan would yield sustained improvements or if alternative strategies would be necessary to stabilize his condition.

Section 5

As the healthcare team continued to monitor Mr. Thompson, the next set of diagnostic results brought both hope and concern regarding his condition. His latest laboratory tests showed a slight improvement in renal function, with his creatinine level decreasing to 1.8 mg/dL from the previous 2.1 mg/dL, suggesting that kidney perfusion might be improving with the optimized fluid management. However, his electrolyte panel revealed a new challenge: his sodium level had dropped to 130 mmol/L, indicating a state of hyponatremia. This electrolyte imbalance raised concerns about the potential exacerbation of his heart failure symptoms and the risk of neurological complications.

In addition to the lab findings, a detailed cardiovascular assessment highlighted a persistently elevated jugular venous pressure and mild peripheral edema, indicating that fluid overload was still a significant issue. Mr. Thompson's blood pressure was recorded at 95/60 mmHg, and his heart rate remained stable but slightly elevated at 92 beats per minute. These findings prompted the team to carefully reconsider his diuretic regimen and fluid intake, balancing the need for aggressive fluid removal with the risk of further compromising his blood pressure and renal function.

The team decided to introduce an angiotensin receptor-neprilysin inhibitor (ARNI) cautiously, given his reduced ejection fraction and ongoing symptoms. They also planned to address the hyponatremia by adjusting his fluid restrictions and considering options such as hypertonic saline if necessary. The multidisciplinary team, including the dietitian and pharmacist, continued to collaborate closely to refine Mr. Thompson's treatment plan, remaining vigilant for any signs of worsening heart failure or new complications. As they awaited the impact of these adjustments, the next 48 hours were crucial in determining whether Mr. Thompson would stabilize or require further intervention to prevent deterioration.